Technical Analysis for CGEN - Compugen Ltd.

Grade Last Price % Change Price Change
F 8.6 1.18% 0.10
CGEN closed up 1.18 percent on Thursday, April 22, 2021, on 58 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical CGEN trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 1.18%
Down 3 Days in a Row Weakness 4.24%
Fell Below 20 DMA Bearish 3.74%
20 DMA Support Bullish 0.35%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.37%
Narrow Range Bar Range Contraction -3.37%
NR7 Range Contraction -3.37%
Inside Day Range Contraction -3.37%
20 DMA Support Bullish -0.69%
Older End-of-Day Signals for CGEN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 15 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Up 2% about 18 hours ago
20 DMA Support about 18 hours ago
Rose Above Previous Day's High about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Compugen Ltd. Description

Compugen Ltd., a therapeutic product discovery company, engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates primarily in the United States, Europe, and Israel. It focuses on the therapeutic proteins and monoclonal antibodies to address unmet needs in the fields of immunology and oncology. The company's therapeutic proteins pipeline includes CGEN-15001, a novel protein for the treatment of autoimmune disorders; CGEN-15021, a novel fusion protein for the treatment of multiple sclerosis, rheumatoid arthritis, and other autoimmune diseases; CGEN-15091, a novel fusion protein for the treatment of multiple sclerosis and autoimmune diseases; CGEN-15031, a fusion protein candidate to treat multiple sclerosis; and CGEN-15051, a fusion protein candidate for the treatment of rheumatoid arthritis. Its monoclonal antibody therapy product candidates include CGEN-15001T, a membrane protein target for the treatment of cancer; CGEN-15022 membrane protein for the treatment of multiple cancers; CGEN-671, a novel drug target for the treatment of multiple epithelial tumors; and CGEN-928 drug target for the treatment of multiple myeloma. Compugen Ltd. was founded in 1993 and is headquartered in Tel Aviv, Israel.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Life Sciences Immunology Treatment Of Cancer Antibodies Cancers Autoimmune Diseases Monoclonal Antibody Monoclonal Antibodies Autoimmune Disease Antibody Therapeutic Product Rheumatoid Arthritis Multiple Sclerosis Biomarker Autoimmunity Multiple Myeloma Immune Disorders Autoimmune Disorders Fusion Protein Compugen Monoclonal Antibody Therapy Treatment Of Multiple Sclerosis Antibody Therapy

Is CGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 19.9
52 Week Low 7.1
Average Volume 1,485,372
200-Day Moving Average 13.38
50-Day Moving Average 9.41
20-Day Moving Average 8.49
10-Day Moving Average 8.51
Average True Range 0.61
ADX 23.36
+DI 16.66
-DI 23.13
Chandelier Exit (Long, 3 ATRs ) 7.48
Chandelier Exit (Short, 3 ATRs ) 9.31
Upper Bollinger Band 9.07
Lower Bollinger Band 7.91
Percent B (%b) 0.6
BandWidth 13.69
MACD Line -0.22
MACD Signal Line -0.30
MACD Histogram 0.0759
Fundamentals Value
Market Cap 711.17 Million
Num Shares 82.7 Million
EPS -0.45
Price-to-Earnings (P/E) Ratio -18.98
Price-to-Sales 0.00
Price-to-Book 8.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.19
Resistance 3 (R3) 9.16 8.92 9.09
Resistance 2 (R2) 8.92 8.77 8.94 9.06
Resistance 1 (R1) 8.76 8.68 8.84 8.80 9.03
Pivot Point 8.53 8.53 8.57 8.55 8.53
Support 1 (S1) 8.37 8.38 8.45 8.40 8.17
Support 2 (S2) 8.13 8.28 8.15 8.14
Support 3 (S3) 7.97 8.13 8.11
Support 4 (S4) 8.01